Porpong (Paul) Boonmak
Education
Ph.D., public health sciences, Queen’s University at Kingston; Master of Population Health Sciences, Washington University in St. Louis; M.D., Chulalongkorn University
Summary of Experience
Dr. Boonmak is an epidemiologist with a strong clinical background, combining formal medical training with expertise in health economics and outcomes research, real-world evidence, and quantitative epidemiologic methods. As a physician, he brings a clinically grounded analytic perspective to the design and evaluation of complex health care research questions. Dr. Boonmak’s research integrates methods from epidemiology, biostatistics, and health services research to evaluate real-world clinical and economic outcomes, including treatment patterns, comparative effectiveness, health care resource utilization, and the economic burden of disease. He has designed and conducted studies using observational databases, administrative claims databases, electronic medical records, surveys, and published literature, and his project experience spans multiple therapeutic areas, including mental health and psychiatric disorders, autoimmune diseases, neurological disorders, and gastrointestinal diseases. Dr. Boonmak’s work has been published in peer-reviewed journals and presented at international conferences on medical and health care research.
-
Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer
Journal of Health Economics and Outcomes Research, 2025
2025Du S, Rossi C, Khilfeh I, Boonmak P, Wong G, Pilon D, Ellis L
-
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and Medicaid-insured adults in the United States: A retrospective matched cohort study
Journal of Affective Disorders, 2025
2025Kale H, Zhdanava M, Pilon D, Sheehan J, Drissen T, Boonmak P, Choudhry Z, Shah A, Jha MK
-
Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United States
Clinical Therapeutics, 2025
2025Harding L, Zhdanava M, Teeple A, Shah A, Boonmak P, Pilon D, Joshi K
-
Comparison of real-world healthcare resource utilization among advanced therapy-naïve and advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or vedolizumab
Current Medical Research and Opinion, 2024
2024Zhdanava M, Kachroo S, Boonmak P, Burbage S, Shah A, Korsiak J, Patrick Lefebvre P, Kerner C, Pilon D
-
Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events
Current Medical Research and Opinion, 2024
2024Zhdanava M, Pesa J, Boonmak P, Cai Q, Pilon D, Choudhry Z, Souayah N
-
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective
Applied Health Economics and Health Policy, 2024
2024Zhdanava M, Pesa J, Boonmak P, Schwartzbein S, Cai Q, Pilon D, Choudhry Z, Lafeuille MH, Lefebvre P, Souayah N
-
Treatment Persistence Among Anti-Tumor Necrosis Factor-experienced Patients With Ulcerative Colitis Switching to a Biologic With a Different Mode of Action or Cycling to Another Anti-Tumor Necrosis Factor Agent
Clinical Therapeutics, 2024
2024Zhdanava M, Burbage S, Boonmak P, Kachroo S, Shah A, Godwin B, Pilon D
-
Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
Advances in Therapy, 2024
2024Zhdanava M, Kachroo S, Boonmak P, Burbage S, Shah A, Korsiak J, Lefebvre P, Kerner C, Pilon D
-
Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naïve Patients with Crohn's Disease and Fistula Initiated on Ustekinumab
Advances in Therapy, 2024
2024Zhdanava M, Kachroo S, Boonmak P, Burbage S, Shah A, Lefebvre P, Kerner C, Pilon D